Literature DB >> 2477644

A method for safe twelve-hour pulmonary preservation.

S H Keshavjee1, F Yamazaki, P F Cardoso, D I McRitchie, G A Patterson, J D Cooper.   

Abstract

The clinical application of lung transplantation is severely limited by the shortage of suitable donor organs. Current techniques of lung preservation allow a maximum of 4 to 6 hours of safe ischemic time. The function of canine left lung allografts stored for 12 hours after being cooled by pulmonary artery flush was studied. Two types of flush solution were used: group I; Euro-Collins solution; group II, low-potassium-dextran solution. Lung function was studied immediately and 3 days after transplantation. This protocol enables study of acute preservation-related lung injury and the delayed manifestations of ischemic and reperfusion injury after a 3-day period of recovery. Inflatable cuffs were placed around each pulmonary artery at operation and were attached to subcutaneous injection ports. Temporarily occluding either pulmonary artery allowed independent study of the native or transplanted lung. Using this model, we were able to demonstrate reliable and reproducible preservation of lungs for 12 hours. The low-potassium-dextran solution provided significantly better immediate function of the preserved lung than the Euro-Collins solution: arterial oxygen tension 509 +/- 15 mm Hg versus 111 +/- 16 mm Hg (p less than 0.0001). Function on the third day was excellent for both groups. Pulmonary artery pressure, pulmonary vascular resistance, and carbon dioxide tension were not significantly different between the groups immediately or on day 3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477644

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  Effects of glucose on rat lung preservation: report of a study conducted on an isolated lung reperfusion model utilizing. Another isolated lung as a "deoxygenator".

Authors:  T Hanagiri; H Igisu; T Shiraishi; M Ikeda; K Yasumoto
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

2.  Morphological changes in rat single lung isografts after long-term survival.

Authors:  M A Hidalgo; S Manek; P R Fryer; B J Fuller; C J Green
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

Review 3.  Overview of clinical lung transplantation.

Authors:  Jonathan C Yeung; Shaf Keshavjee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 4.  The evolution of techniques and indications for lung transplantation.

Authors:  J D Cooper
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

Review 5.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

Review 6.  Procurement of lungs from brain-dead donors.

Authors:  Prasad Krishnan; Sahar-Al-Sadat Sahar Saddoughi
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-03-19

7.  Comparison of lung preservation solutions in human lungs using an ex vivo lung perfusion experimental model.

Authors:  Israel L Medeiros; Paulo M Pêgo-Fernandes; Alessandro W Mariani; Flávio G Fernandes; Fernando V Unterpertinger; Mauro Canzian; Fabio B Jatene
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

8.  Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.

Authors:  D F McAuley; G F Curley; U I Hamid; J G Laffey; J Abbott; D H McKenna; X Fang; M A Matthay; J W Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-14       Impact factor: 5.464

9.  Comparison of Celsior and Perfadex lung preservation solutions in rat lungs subjected to 6 and 12 hours of ischemia using an ex-vivo lung perfusion system.

Authors:  Arteiro Queiroz Menezes; Paulo Manuel Pêgo-Fernandes; Paulo Francisco Guerreiro Cardoso; Karina Andrighetti de Oliveira Braga; Natalia Aparecida Nepomuceno; Rogerio Pazetti; Aristides Tadeu Correia; Mauro Canzian; Jacqueline Klarosk Santim; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.